Other sex hormone and similar
(Systemic Sex Hormone)
Indication: Treatment of symptoms resulting from the natural or surgical menopause in post menopausal women. Prevention of osteoporosis in women who have gone through the menopause and are at high risk of fractures, but cannot take other medicines used to prevent osteoporosis.
Dosage & Administration: Treatment of symptoms resulting from the natural or surgical menopause.
Prevention of post-menopausal bone mineral density loss: The recommended dose is 2.5 mg once daily.
Improvement of symptoms generally occurs within a few weeks, but optimal results are obtained when therapy is continued for at least 3 months. Women experiencing a natural menopause should commence treatment with tibolone at least 12 months after their last natural bleed. In case of a surgical menopause, treatment with tibolone may commence immediately.
Preparation: Renorma® Tablet : Each box contains 30 tablets.